| Home > Publications database > Single cell transcriptional evolution of myeloid leukemia of Down syndrome. |
| Journal Article | DKFZ-2026-00972 |
; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ;
2026
Springer Nature
[London]
Abstract: Children with Down syndrome have a 150-fold increased risk of developing myeloid leukaemia (ML-DS). Unusually for a childhood leukaemia, ML-DS arises from a preleukaemic state, termed transient abnormal myelopoiesis (TAM), via a conserved sequence of mutations. Here, we examine the relationship between the genetic and transcriptional evolution of ML-DS from natural variation; a rich collection of primary patient samples and foetal tissues with a range of constitutional karyotypes. We distil transcriptional consequences of each genetic step in ML-DS evolution, utilising single-cell mRNA sequencing, complemented by phylogenetic analyses in progressive disease. We find that transcriptional changes induced by the TAM-defining GATA1 mutations are retained in, and account for most of the ML-DS transcriptome. The GATA1 transcriptome pervades all stages of ML-DS, including progressive disease that had undergone genetic evolution. Our approach delineates the transcriptional evolution of ML-DS and provides an analytical blueprint for distiling consequences of mutations within their pathophysiological context.
Keyword(s): Down Syndrome: genetics (MeSH) ; Down Syndrome: complications (MeSH) ; Humans (MeSH) ; GATA1 Transcription Factor: genetics (MeSH) ; Mutation (MeSH) ; Single-Cell Analysis: methods (MeSH) ; Leukemia, Myeloid: genetics (MeSH) ; Leukemia, Myeloid: pathology (MeSH) ; Evolution, Molecular (MeSH) ; Transcriptome: genetics (MeSH) ; Phylogeny (MeSH) ; Leukemoid Reaction: genetics (MeSH) ; Male (MeSH) ; Child (MeSH) ; Female (MeSH) ; Transcription, Genetic (MeSH) ; GATA1 Transcription Factor ; GATA1 protein, human
|
The record appears in these collections: |